Roderick Matheson - Marvel Biosciences Executive CEO
| MRVL Stock | 0.17 0.01 6.25% |
CEO
Roderick Matheson is Executive CEO of Marvel Biosciences Corp
| Address | 505 8th Avenue S.W., Calgary, AB, Canada, T2P 1G2 |
| Phone | 403 770 2469 |
| Web | https://marvelbiotechnology.com |
Marvel Biosciences Management Efficiency
The company has return on total asset (ROA) of (1.5364) % which means that it has lost $1.5364 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.803) %, meaning that it generated substantial loss on money invested by shareholders. Marvel Biosciences' management efficiency ratios could be used to measure how well Marvel Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Marvel Biosciences' Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 1.61 in 2024, whereas Return On Tangible Assets are likely to drop (4.11) in 2024. At this time, Marvel Biosciences' Total Current Assets are fairly stable compared to the past year. Total Assets is likely to climb to about 870 K in 2024, whereas Return On Tangible Assets are likely to drop (4.11) in 2024. Marvel Biosciences Corp (MRVL) is traded on TSX Venture Exchange in Canada and employs 4 people. Marvel Biosciences is listed under Biotechnology category by Fama And French industry classification.Management Performance
| Return On Equity | -3.8 | ||||
| Return On Asset | -1.54 |
Marvel Biosciences Corp Leadership Team
Elected by the shareholders, the Marvel Biosciences' board of directors comprises two types of representatives: Marvel Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marvel. The board's role is to monitor Marvel Biosciences' management team and ensure that shareholders' interests are well served. Marvel Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marvel Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jacqueline Groot, Corporate Secretary | ||
| CPA CMA, Chief Officer | ||
| Mark MBA, Chief President | ||
| Roderick Matheson, Executive CEO |
Marvel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Marvel Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Marvel Stock Analysis
When running Marvel Biosciences' price analysis, check to measure Marvel Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marvel Biosciences is operating at the current time. Most of Marvel Biosciences' value examination focuses on studying past and present price action to predict the probability of Marvel Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marvel Biosciences' price. Additionally, you may evaluate how the addition of Marvel Biosciences to your portfolios can decrease your overall portfolio volatility.